Your browser doesn't support javascript.
loading
Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma".
Eger, Katrien; Kroes, Johannes A; Ten Brinke, Anneke; Bel, Elisabeth H.
Affiliation
  • Eger K; Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: k.a.eger@amsterdamumc.nl.
  • Kroes JA; Department of Clinical Pharmacy and Pharmacology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.
  • Ten Brinke A; Department of Respiratory Medicine, Medical Center Leeuwarden, Leeuwarden, the Netherlands.
  • Bel EH; Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
J Allergy Clin Immunol Pract ; 10(7): 1936, 2022 07.
Article in En | MEDLINE | ID: mdl-35809997
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Biological Products Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Biological Products Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2022 Document type: Article